PROBIOTIX HEALTH LS-05 (X90) — Cash Flow-to-Debt Ratio
Latest as of December 2024:
-4.17x
PROBIOTIX HEALTH LS-05 (X90) has a Cash Flow-to-Debt Ratio of -4.17x as of December 2024, meaning its operating cash flow of €-1.06 Million could theoretically repay -4% of its total liabilities (€254.00K) in one year. See PROBIOTIX HEALTH LS-05 (X90) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-4.17x
Operating CF / Total Liabilities
Operating Cash Flow
€-1.06 Million
EUR
Total Liabilities
€254.00K
EUR
Data as of
Dec 2024
Most recent filing
PROBIOTIX HEALTH LS-05 Cash Flow-to-Debt Ratio (2022–2024)
Historical debt coverage capacity for PROBIOTIX HEALTH LS-05 across 3 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of PROBIOTIX HEALTH LS-05.
Annual Cash Flow-to-Debt Ratio for PROBIOTIX HEALTH LS-05 (2022–2024)
Year-by-year debt coverage analysis for PROBIOTIX HEALTH LS-05.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.17x | €-1.06 Million | €254.00K | ▼ -1024.0% |
| 2023 | -0.37x | €-238.00K | €641.00K | ▲ +79.6% |
| 2022 | -1.82x | €-638.02K | €350.91K | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.